Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-189708
Filing Date
2010-08-16
Accepted
2010-08-16 11:00:41
Documents
8
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2053876
2 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 10250
3 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 10107
4 SECTION 302 CERTIFICATION OF CEO dex321.htm EX-32.1 3223
5 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2928
6 GRAPHIC g86129tx_pg010.jpg GRAPHIC 61969
7 GRAPHIC g86129tx_pg015.jpg GRAPHIC 97901
8 GRAPHIC g86129tx_pg019.jpg GRAPHIC 134802
  Complete submission text file 0001193125-10-189708.txt   2488213
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-51383 | Film No.: 101017725
SIC: 2834 Pharmaceutical Preparations